ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Adjuvant immunotherapy in early-stage resectable non-small cell lung cancer: A new milestone

Tang, Wen-Fang; Ye, Hong-Yu; Tang, Xuan; Su, Jian-Wei; Xu, Kang-Mei; Zhong, Wen-Zhao*; Liang, Yi*广东省人民医院; 南方医科大学; y
Frontiers in Oncology2023-1-26DOI: 10.3389/fonc.2023.1063183
4被引8阅读
引用收藏
分享

摘要

Currently, chemotherapy is the standard adjuvant treatment for early-stage non-small cell lung cancer (NSCLC). However, adjuvant cisplatin-based chemotherapy after surgery has been shown to improve 5-year survival rates by only 4-5%. Immunotherapy using immune checkpoint inhibitors (ICIs) has revolutionized the treatment of advanced NSCLC, there is a growing interest in the role of immunotherapy in early-stage NSCLC. Here, we summarize the rationale for adjuvant immunotherapy, including the postoperative immunosuppressive environment and immunological effects of platinum chemotherapy. Many ongoing clinical trials and the related progress in adjuvant immunotherapy in early-stage resectable NSCLC are discussed. Furthermore, we highlight several unresolved challenges, including markers predictive of treatment benefit, the efficacy of treatment for some oncogene-addicted tumors, the optimal combination therapy, the duration of adjuvant immunotherapy, and optimal selection between neoadjuvant and adjuvant immunotherapy. Early findings in some clinical trials are promising, and updated overall survival results will be useful for validating the current role of adjuvant immunotherapy, particularly in the context of perioperative strategy.

学科与关键词

关键词
resectable non-small cell lung canceradjuvant immunotherapyimmune checkpoint inhibitionimmune suppression environmentchemotherapy
相关
加载中…
  • Neoadjuvant immunotherapy for non-small cell lung cancer: State of the art
    Kang, Jin; Zhang, Chao; Zhong, Wen-Zhao*Cancer Communications, 2021, 41(4): 287-302.被引 62
  • Perioperative targeted therapy for oncogene-driven NSCLC
    Liu, Si -Yang; Zhang, Jia-Tao; Zeng, Kang-Hui; Wu, Yi-Long*Lung Cancer, 2022, 172: 160-169.被引 16
  • Expert consensus on perioperative immunotherapy for local advanced non-small cell lung cancer
    Qiu, Bin; Cai, Kaican; Chen, Chun; Chen, Jun; Chen, Ke-Neng; Chen, Qi-Xun; Cheng, Chao; Dai, Tian-Yang; Fan, Junqiang; Fan, Zhaohui; Hu, Jian; Hu, Wei-Dong; Huang, Yun-Chao; Jiang, Ge-Ning; Jiang, Jie; Jiang, Tao; Jiao, Wen-Jie; Li, He-Cheng; Li, Qiang; Liao, Yong-De; Liu, Hong-Xu; Liu, Jun-Feng; Liu, Lunxu; Liu, Yang; Long, Hao; Luo, Qing-Quan; Ma, Hai-Tao; Mao, Nai-Quan; Pan, Xiao-Jie; Tan, Fengwei; Tan, Li-Jie; Tian, Hui; Wang, Dong; Wang, Wen-Xiang; Wei, Li; Wu, Nan; Wu, Qing-ChenTranslational Lung Cancer Research, 2021, 10(9): 3713-3736.被引 9
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Oncology
发表日期
2023-01-26
卷期
第 13 卷
页码
1063183
DOI
10.3389/fonc.2023.1063183
成果收录
SCIE
资助标注
National Natural Science Foundation [82203421, Y-tongshu2021/ms-0096]; Zhongshan City People's Hospital Major Project (Top Youth Program) [81872510]; Zhongshan Science and Technology Bureau Project [B2021003]; Beijing Xisike Clinical Oncology Research Foundation [2022B1140]; High-Level Hospital Construction Project [DFJH201801]; Guangdong Provincial People's Hospital Young Talent Project [KJ012019085]; GDPH Scientific Research Funds for Leading Medical Talents and Distinguished Young Scholars in Guangdong Province [KJ012019449]; Guangdong Basic and Applied Basic Research Foundation [2019B1515130002]

作者

  • T

    Tang, Wen-Fang (第一作者)

    zhongshan city peoples hosp

  • Y

    Ye, Hong-Yu

    zhongshan city peoples hosp

查看全部 7 位作者收起作者
  • T

    Tang, Xuan

    zhongshan city peoples hosp

  • S

    Su, Jian-Wei

    zhongshan city peoples hosp

  • X

    Xu, Kang-Mei

    zhongshan city peoples hosp

  • Z

    Zhong, Wen-Zhao (通讯)

    guangdong prov peoples hosp · southern med univ

  • L

    Liang, Yi (通讯)

    zhongshan city peoples hosp

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417